HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization

被引：0
|
作者：
Ntoulia, Maria
Kaklamanis, Loukas
Valavanis, Christos
Kafousi, Maria
Stathopoulos, Efstathios
Arapantoni, Petroula
Mavroudis, Dimitris
Georgoulias, Vassilis
Lianidou, Evi S.
机构：
[1] Univ Athens, Athens, Greece
[2] Onassis Cardiac Surg Ctr, Athens, Greece
[3] Metaxas Mem Hosp, Piraeus, Greece
[4] Univ Gen Hosp, Iraklion, Crete, Greece
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3627
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in-situ-hybridization
    Shanmugalingam, A.
    Hitos, K.
    Pathmanathan, N.
    Edirimmane, S.
    Hughes, M. T.
    Ngui, N. K.
    BREAST, 2023, 68 : S29 - S29
  • [22] Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer
    Gupta, D
    Middleton, LP
    Whitaker, MJ
    Abrams, J
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (03) : 381 - 387
  • [23] Evaluation of HER2 gene status in breast cancer by chromogenic in situ hybridization:: Comparison with immunohistochemistry
    Kounelis, S
    Kapranos, N
    Malamos, N
    Kouri-Bairaktari, E
    ANTICANCER RESEARCH, 2005, 25 (2A) : 939 - 946
  • [24] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [25] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    Wang, Lin
    Wang, Xiaobei
    Nie, Xiu
    Ma, Ling
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 354 - 358
  • [26] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    王琳
    王晓蓓
    聂秀
    马玲
    Current Medical Science, 2009, 29 (03) : 354 - 358
  • [27] Absence of CMV Components in High Grade Gliomas by Real-Time PCR, Immunohistochemistry and Chromogenic In-Situ Hybridization
    Guner, Gunes
    Rodriguez, Fausto
    Hicks, Jessica
    Ye, Xiaobu
    Grossman, Stuart
    Burger, Peter
    Eberhart, Charles G.
    De Marzo, Angelo M.
    Boger, Ravit
    Holdhoff, Matthias
    LABORATORY INVESTIGATION, 2016, 96 : 430A - 430A
  • [28] Absence of CMV Components in High Grade Gliomas by Real-Time PCR, Immunohistochemistry and Chromogenic In-Situ Hybridization
    Guner, Gunes
    Rodriguez, Fausto
    Hicks, Jessica
    Ye, Xiaobu
    Grossman, Stuart
    Burger, Peter
    Eberhart, Charles G.
    De Marzo, Angelo M.
    Boger, Ravit
    Holdhoff, Matthias
    MODERN PATHOLOGY, 2016, 29 : 430A - 430A
  • [29] Real-time reverse transcription-PCR and fluorescence in-situ hybridization are complementary to understand the mechanisms involved in HER-2/neu overexpression in human breast carcinomas
    Vanden Bempt, I
    Vanhentenrijk, V
    Drijkoningen, M
    Wlodarska, I
    Vandenberghe, P
    De Wolf-Peeters, C
    HISTOPATHOLOGY, 2005, 46 (04) : 431 - 441
  • [30] Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene expression in breast cancer
    Gupta, D
    Middleton, LP
    Whitaker, MJ
    Abrams, J
    MODERN PATHOLOGY, 2003, 16 (01) : 322A - 322A
12345